2021
DOI: 10.1016/j.pharmthera.2021.107860
|View full text |Cite
|
Sign up to set email alerts
|

Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 40 publications
(24 citation statements)
references
References 154 publications
0
23
0
1
Order By: Relevance
“…Some of the most widely used anticancer drugs nowadays are the tyrosine kinase inhibitors and the tubulin polymerisation inhibitors, with many new representatives of these classes being launched each year 69 . Thus, in this paragraph I will examine a set of hybridisation approaches which involve CAIs and several other, rather heterogeneous classes of antitumor agents, among which the epidermal growth factor receptor (EGFR) antagonists (this protein has kinase activity) 70 , the 15-lipoxygenase (15-LOX)/COX-2 (multitargeting of tree different proteins) inhibitors 71 , the telomerase inhibitors 72 , the P-glycoprotein (P-gp) inhibitors 73 , and the thioredoxin inhibitors 74 , 75 .…”
Section: Antitumor Hybrid Drugs Incorporating Cais Conjugated With Other Cheotypesmentioning
confidence: 99%
See 1 more Smart Citation
“…Some of the most widely used anticancer drugs nowadays are the tyrosine kinase inhibitors and the tubulin polymerisation inhibitors, with many new representatives of these classes being launched each year 69 . Thus, in this paragraph I will examine a set of hybridisation approaches which involve CAIs and several other, rather heterogeneous classes of antitumor agents, among which the epidermal growth factor receptor (EGFR) antagonists (this protein has kinase activity) 70 , the 15-lipoxygenase (15-LOX)/COX-2 (multitargeting of tree different proteins) inhibitors 71 , the telomerase inhibitors 72 , the P-glycoprotein (P-gp) inhibitors 73 , and the thioredoxin inhibitors 74 , 75 .…”
Section: Antitumor Hybrid Drugs Incorporating Cais Conjugated With Other Cheotypesmentioning
confidence: 99%
“…Zhang et al. 70 reported hybrids incorporating the tyrosine kinase inhibitory fragments found in erlotinib and gefitinib, clinically used anticancer agents 69 and benzenesulphonamides with CA inhibitory activity, of types 36 ( Figure 13 ) which were shown to possess antiproliferative activity against several cell lines, such as A549, A431 and H1975. Few of the compounds were also tested for the inhibition of EGFR (wild type and mutant) and hCA II and IX, showing nanomolar activity for the first protein, and micromolar ones for the CAs.…”
Section: Antitumor Hybrid Drugs Incorporating Cais Conjugated With Other Cheotypesmentioning
confidence: 99%
“…4-(furan-2ylmethylene)-2-(3,4,5-trimethoxyphenyl)oxazol-5(4H)-one (1) is the starting material and was prepared by condensation of 2-(3,4,5-trimethoxybenzamide)acetic acid, furfural and acetic anhydride in the presence of anhydrous sodium acetate in an oil bath at 80-100 • C according to literature reported [25]. The structure of the starting oxazolone 1 was confirmed by IR, 1 H-NMR and 13 C-NMR spectra. IR spectrum of oxazolone 1 showed the characteristic C=O stretching absorption of lactone ring at ν 1805 cm −1 .…”
Section: Chemistrymentioning
confidence: 99%
“…The structures of compounds 4a-e were confirmed using IR and NMR spectra. 1 H-NMR spectrum of compound 4c as a representative example showed the presence of characteristic two exchangeable proton (2NH) at δ 9.94 ppm. The 13 C-NMR spectrum of compound 4c showed the presence of extra signals related to aromatic carbons.…”
Section: Chemistrymentioning
confidence: 99%
See 1 more Smart Citation